Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04078841 · ClinicalTrials.gov registry record · Phase 1

Treating Post-Lyme Disease Syndrome With Acetogenins

A Phase 1 study, sponsored by Optimal Health Research.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target

NCT04078841 is a Phase 1 study that has completed, run by Optimal Health Research. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04078841, a Phase 1 study, has completed, sponsored by Optimal Health Research.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target

Study Summary

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

Interventions

  • DIETARY_SUPPLEMENT ReaLife+ (RLP)
  • OTHER Inert Brown powder

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-07-01
Est. Completion 2020-01-30
Phase Phase 1

Sponsor

Optimal Health Research

5 total trials

What the Registry Record Tells You About NCT04078841

The ClinicalTrials.gov registry entry for NCT04078841 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optimal Health Research, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ReaLife+ (RLP) is the first listed.

NCT04078841 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04078841 about?

NCT04078841 is a clinical study titled "Treating Post-Lyme Disease Syndrome With Acetogenins". To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

What is the current status of trial NCT04078841?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2019-07-01. Estimated completion is 2020-01-30.

What interventions are being tested in trial NCT04078841?

The interventions under investigation include: ReaLife+ (RLP) (DIETARY_SUPPLEMENT), Inert Brown powder (OTHER).

Who is sponsoring clinical trial NCT04078841?

This trial is sponsored by Optimal Health Research, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.